Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. ($DNLI), made two open market sales of company shares in the last 365 days, totaling $51,684. Her most recent sale occurred on August 13, 2025. These transactions rank 10,357th out of 11,678 insiders in our database by sale value, well below the average of $8.6 million across 6.4 transactions per insider. Ho made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 12, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 2937 | $13.58 | 425,610.0000 | 164,473,772 | 0.69% | 0.00% |
| Aug. 13, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 806 | $14.64 | 424,804.0000 | 164,473,772 | 0.19% | 0.00% |
| Aug. 5, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | M | Common Stock | 44655 | $0.68 | 428,547.0000 | 164,473,772 | 11.63% | 0.03% |
| Aug. 5, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | M | Stock Option (right to buy) | 44655 | $0.00 | 62,500.0000 | 164,473,772 | 41.67% | 0.03% |
| July 31, 2025 | Royalty Pharma plc | $RPRX | Ho Carole | Director | A | Class A Ordinary Shares | 5806 | $0.00 | 8,558.0000 | 594,108,000 | 210.97% | 0.00% |
| July 31, 2025 | Royalty Pharma plc | $RPRX | Ho Carole | Director | A | Class A Ordinary Shares | 2752 | $0.00 | 2,752.0000 | 594,108,000 | 9999.99% | 0.00% |
| June 4, 2025 | Beam Therapeutics Inc. | $BEAM | Ho Carole | Not found | A | Stock Option (Right to Buy) | 33662 | $0.00 | 33,662.0000 | 82,313,008 | 9999.99% | 0.04% |
| Jan. 6, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 12255 | $20.22 | 386,799.0000 | 164,473,772 | 3.07% | 0.01% |
| Jan. 7, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 2907 | $20.81 | 383,892.0000 | 164,473,772 | 0.75% | 0.00% |
| Jan. 3, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | A | Stock Option (right to buy) | 162540 | $0.00 | 162,540.0000 | 164,473,772 | 9999.99% | 0.10% |
| Jan. 3, 2025 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | A | Common Stock | 54180 | $0.00 | 399,054.0000 | 164,473,772 | 15.71% | 0.03% |
| Nov. 25, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | M | Stock Option (right to buy) | 17845 | $0.00 | 107,155.0000 | 169,456,988 | 14.28% | 0.01% |
| Nov. 25, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | M | Common Stock | 17845 | $0.68 | 344,874.0000 | 169,456,988 | 5.46% | 0.01% |
| Aug. 20, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 2453 | $23.79 | 347,034.0000 | 137,370,897 | 0.70% | 0.00% |
| Aug. 21, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 14098 | $24.41 | 332,936.0000 | 137,370,897 | 4.06% | 0.01% |
| Aug. 21, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 5907 | $24.96 | 327,029.0000 | 137,370,897 | 1.77% | 0.00% |
| Aug. 13, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 2337 | $22.89 | 349,487.0000 | 137,370,897 | 0.66% | 0.00% |
| June 5, 2024 | Beam Therapeutics Inc. | $BEAM | Ho Carole | Not found | A | Stock Option (Right to Buy) | 23114 | $0.00 | 23,114.0000 | 77,151,771 | 9999.99% | 0.03% |
| Feb. 13, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 2784 | $17.29 | 353,229.0000 | 137,370,897 | 0.78% | 0.00% |
| Feb. 14, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 1405 | $17.79 | 351,824.0000 | 137,370,897 | 0.40% | 0.00% |
| Jan. 10, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 4668 | $19.02 | 356,013.0000 | 137,370,897 | 1.29% | 0.00% |
| Jan. 5, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | S | Common Stock | 9972 | $19.43 | 360,681.0000 | 137,370,897 | 2.69% | 0.01% |
| Jan. 3, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | A | Common Stock | 53720 | $0.00 | 370,653.0000 | 137,370,897 | 16.95% | 0.04% |
| Jan. 3, 2024 | Denali Therapeutics Inc. | $DNLI | Ho Carole | Chief Medical Officer | A | Stock Option (right to buy) | 161160 | $0.00 | 161,160.0000 | 137,370,897 | 9999.99% | 0.12% |
| June 6, 2023 | Beam Therapeutics Inc. | $BEAM | Ho Carole | Not found | A | Stock Option (Right to Buy) | 16532 | $0.00 | 16,532.0000 | 70,015,305 | 9999.99% | 0.02% |